Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/04/2010US20100280005 Renin Inhibitors
11/04/2010US20100280004 Small molecule correctors of deltaf508 cftr trafficking
11/04/2010US20100280003 Combinations of jak inhibitors
11/04/2010US20100280002 Aminopyridine-derivatives as inductible no-synthase inhibitors
11/04/2010US20100280001 Imidazoquinolines with immuno-modulating properties
11/04/2010US20100280000 Therapeutic agents 713
11/04/2010US20100279998 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors
11/04/2010US20100279997 Analgesic that binds filamin a
11/04/2010US20100279996 Novel analgesic that binds filamin a
11/04/2010US20100279995 Novel Ansamycin Derivatives
11/04/2010US20100279994 Ansamycin Formulations and Methods of Use Thereof
11/04/2010US20100279993 Pharmaceutical Propylene Glycol Solvate Compositions
11/04/2010US20100279992 Use of lanostane and poria extract in treating cachexia
11/04/2010US20100279991 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
11/04/2010US20100279990 Antiproliferative compounds, compositions and methods of use
11/04/2010US20100279989 Oral contraception with trimegestone
11/04/2010US20100279988 Transdermal delivery system for hormones and steroids
11/04/2010US20100279987 Compositions containing chalcones and use thereof
11/04/2010US20100279986 Heterocyclic derived metalloprotease inhibitors
11/04/2010US20100279985 Liver function-protecting agent
11/04/2010US20100279984 Pharmaceutical compositions containing benfotiamine and one or one more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin
11/04/2010US20100279983 Novel inhibitors of beta-lactamase
11/04/2010US20100279982 Cellulose derivative
11/04/2010US20100279981 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid
11/04/2010US20100279980 Moenomycin biosynthesis-related compositions and methods of use thereof
11/04/2010US20100279979 Immunopotentiating agent for use in animals
11/04/2010US20100279978 Methods of reducing the severity of mucositis
11/04/2010US20100279977 Compositions and methods for treating cancer
11/04/2010US20100279976 Use of artemisinin and its derivatives in cancer therapy
11/04/2010US20100279975 Compounds and methods associated with differential methylation of human papilloma virus genomes in epithelial cells
11/04/2010US20100279974 Nucleosides With Non-Natural Bases as Anti-Viral Agents
11/04/2010US20100279973 Synthesis of purine nucleosides
11/04/2010US20100279971 Antifolate compounds for the treatment of melanoma
11/04/2010US20100279970 Method of reducing intraocular pressure in humans
11/04/2010US20100279969 Azido purine nucleosides for treatment of viral infections
11/04/2010US20100279968 Mutagenic Nucleoside Analogs for the Treatment of Viral Disease
11/04/2010US20100279967 Compositions and methods for treating cancer
11/04/2010US20100279966 Compositions and methods for treating cancer
11/04/2010US20100279965 Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
11/04/2010US20100279964 Angular Pyranocoumarins, Process for Preparation and Uses Thereof
11/04/2010US20100279963 Dicarbonyl derivatives and methods of use
11/04/2010US20100279962 Monosebacate of pyrazole derivative
11/04/2010US20100279961 Pharmaceutical composition having a trihydroxy-chromenone derivative
11/04/2010US20100279960 Biotinylated hexadecasaccharides, preparation and use thereof
11/04/2010US20100279959 Medium-Chain Length Fatty Acids, Glycerides and Analogues as Neutrophil Survival and Activation Factors
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279957 Predicting responsiveness to cancer therapeutics
11/04/2010US20100279956 Biomarkers For Fatty Liver Disease And Methods Using The Same
11/04/2010US20100279921 Impaired wound healing compositions and treatments
11/04/2010US20100279919 Compositions comprising human integrin-linked kinase-sirna and methods of use thereof
11/04/2010US20100279906 Formulations comprising an anti-microbial composition
11/04/2010US20100279861 Antifungal Agents
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100279327 Method of treating diseases with parp inhibitors
11/04/2010US20100278997 Preparation for restenosis prevention
11/04/2010US20100278949 Pre-procedure meal regimen
11/04/2010US20100278941 Enhanced erythropoiesis and iron metabolism
11/04/2010US20100278937 Compositions and methods to prevent and/or treat cancer with pa-card
11/04/2010US20100278936 Composition for treating skin lesions
11/04/2010US20100278933 Kinase inhibitor compounds
11/04/2010US20100278932 Polymer micelles containing sn-38 for the treatment of cancer
11/04/2010US20100278931 Porous silicon drug-eluting particles
11/04/2010US20100278928 Polymer micelles containing anthracylines for the treatment of cancer
11/04/2010US20100278927 Polymeric micelles for polynucleotide encapsulation
11/04/2010US20100278926 Controlled Release Oral Dosage Form
11/04/2010US20100278925 Formulations of organo-platinic compounds in the presence of associative polymers, products thus obtained and uses thereof
11/04/2010US20100278921 Solid oral formulation of abt-263
11/04/2010US20100278920 Polyacrylate Nanoparticle Drug Delivery
11/04/2010US20100278918 Extended release formulation of nevirapine
11/04/2010US20100278917 Formulations and Methods of Treating Inflammatory Bowel Disease
11/04/2010US20100278915 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
11/04/2010US20100278914 Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same
11/04/2010US20100278912 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
11/04/2010US20100278911 Controlled release preparation
11/04/2010US20100278909 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
11/04/2010US20100278906 Moisturizing antimicrobial composition
11/04/2010US20100278905 Stabilized lipid formulation of apoptosis promoter
11/04/2010US20100278903 Prophylactic and immunomodulatory compositions and uses
11/04/2010US20100278901 Compositions and methods of making rapidly dissolving ionically masked formulations
11/04/2010US20100278898 Intraocular pressure reduction with intracameral bimatoprost implants
11/04/2010US20100278897 Intraocular bioactive agent delivery system with molecular partitioning system
11/04/2010US20100278896 Solid compositions
11/04/2010US20100278895 Antioxidants and antimicrobial accessories including antioxidants
11/04/2010US20100278894 Antioxidants and antimicrobial accessories including antioxidants
11/04/2010US20100278886 Personal care dissolvable films
11/04/2010US20100278885 C70-Containing Liposome, Method for Producing the Same, and Use of the Same
11/04/2010US20100278879 Stable pharmaceutical composition and methods of using same
11/04/2010US20100278878 Quetiapine salts and their polymorphs
11/04/2010US20100278877 Body tissue filling material and method for production thereof
11/04/2010US20100278875 Prostaglandin e2 (pge2) as an adjuvant in monoclonal antibody generation
11/04/2010US20100278874 Reagents and methods for cancer treatment and prevention
11/04/2010US20100278848 Tumor antigen bfy3 for prevention and/or treatment of cancer
11/04/2010US20100278843 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
11/04/2010US20100278842 Anti-ephb2 antibodies and methods using same
11/04/2010US20100278841 DOWN-REGULATION OF MORTALIN BY siRNA
11/04/2010US20100278838 Epha2 monoclonal antibodies and methods of use thereof
11/04/2010US20100278837 Compositions And Methods For Reducing Cancer And Inflammation
11/04/2010US20100278836 Diagnostic and therapeutic methods and compositions for cardiovascular disease
11/04/2010US20100278835 Novel compounds 660
11/04/2010US20100278833 Thiophene-imidazopyridines
1 ... 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 ... 7860